Who Generates More Revenue? Walgreens Boots Alliance, Inc. or Alkermes plc

Walgreens vs. Alkermes: A Decade of Revenue Growth

__timestampAlkermes plcWalgreens Boots Alliance, Inc.
Wednesday, January 1, 201461878900076392000000
Thursday, January 1, 2015628335000103444000000
Friday, January 1, 2016745694000117351000000
Sunday, January 1, 2017903374000118214000000
Monday, January 1, 20181094274000131537000000
Tuesday, January 1, 20191170947000120074000000
Wednesday, January 1, 20201038756000121982000000
Friday, January 1, 20211173751000132509000000
Saturday, January 1, 20221111795000132703000000
Sunday, January 1, 20231663405000139081000000
Monday, January 1, 20241557632000147658000000
Loading chart...

Unveiling the hidden dimensions of data

Revenue Showdown: Walgreens Boots Alliance vs. Alkermes

In the competitive landscape of the pharmaceutical and healthcare industry, revenue generation is a key indicator of success. Over the past decade, Walgreens Boots Alliance, Inc. has consistently outperformed Alkermes plc in terms of revenue. From 2014 to 2023, Walgreens' revenue surged by approximately 82%, peaking at an impressive $139 billion in 2023. In contrast, Alkermes saw a more modest growth of around 169%, reaching $1.66 billion in the same year.

While Alkermes has shown significant growth in percentage terms, Walgreens' sheer scale and market presence have kept it ahead in absolute revenue figures. The data for 2024 is incomplete, but Walgreens is projected to continue its upward trajectory. This comparison highlights the diverse strategies and market positions of these two industry players, offering insights into their financial health and future potential.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025